SGMO - Sangamo Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6466
Avg. Estimate-0.18-0.22-0.72-0.73
Low Estimate-0.22-0.25-0.78-1.07
High Estimate-0.11-0.18-0.65-0.01
Year Ago EPS-0.14-0.23-1.02-0.72
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6466
Avg. Estimate11.43M8.68M34.93M52.21M
Low Estimate8M3.4M31.49M28.45M
High Estimate14.7M10.7M38.19M121.3M
Year Ago Sales8.92M3.42M19.39M34.93M
Sales Growth (year/est)28.10%153.40%80.20%49.50%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.25-0.26-0.19-0.19
EPS Actual-0.14-0.23-0.17-0.15
Difference0.110.030.020.04
Surprise %44.00%11.50%10.50%21.10%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.18-0.22-0.72-0.73
7 Days Ago-0.18-0.23-0.73-0.74
30 Days Ago-0.18-0.23-0.72-0.74
60 Days Ago-0.18-0.23-0.72-0.74
90 Days Ago-0.22-0.24-0.82-0.8
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/A111
Up Last 30 DaysN/A111
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesSGMOIndustrySectorS&P 500
Current Qtr.-28.60%N/AN/A0.26
Next Qtr.4.30%N/AN/A0.34
Current Year29.40%N/AN/A0.09
Next Year-1.40%N/AN/A0.15
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A